Extracorporeal photopheresis in combination with anti-TNF treatment

摘要

Disclosed is the use of a TNF-alpha antagonist in the preparation of a medicament for the treatment of an autoimmune disease or the amelioration of one or more symptoms thereof in a subject in need thereof, wherein the medicament further comprises a population of cells that has been subjected to an apoptosis-inducing treatment.